Methylene Chloride

Methylene Chloride

SCHEMBL37645

ClCCl.O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Methylene Chloride. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3253 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024119468-A1 TREATMENT METHOD FOR DICHLOROMETHANE IN ACESULFAME PRODUCTION 安徽金禾实业股份有限公司 2024-06-13 WO claimed
CN-118027122-A New anti-aging active iridoid component in eucommia ulmoides leaves as well as preparation method and application thereof 贵州省天然产物研究中心 2024-05-14 CN claimed
CN-115304661-B Cyclic peptide compound and application thereof 西南民族大学 2024-03-15 CN claimed
CN-116332720-B Recovery and purification method of waste solvent 四川熔增环保科技有限公司 2024-03-12 CN claimed
CN-116173159-B Zedoary turmeric oil sulfonate, and preparation method and application thereof 北京中医药大学东直门医院 2024-02-02 CN claimed
CN-117438133-A Low-temperature sintered silver paste and preparation method thereof 长沙先进电子材料工业技术研究院有限公司 2024-01-23 CN claimed
CN-116332720-A Recovery and purification method of waste solvent 四川熔增环保科技有限公司 2023-06-27 CN claimed
CN-116234789-A Treatment method of dichloromethane in acesulfame potassium production 安徽金禾实业股份有限公司 2023-06-06 CN claimed
CN-112107690-B Preparation method of camptothecine drug nanoparticles 浙江工业大学 2023-05-30 CN claimed
CN-116173159-A Zedoary turmeric oil sulfonate, and preparation method and application thereof 北京中医药大学东直门医院 2023-05-30 CN claimed
EP-1680430-A2 PROCESSES FOR PREPARING DIFFERENT FORMS OF (S)-(+)- CLOPIDOGREL BISULFATE CADILA HEALTHCARE LTD. (IN) 2006-07-19 EP claimed
WO-2005063708-A2 PROCESSES FOR PREPARING DIFFERENT FORMS OF (S)-(+)- CLOPIDOGREL BISULFATE CADILA HEALTHCARE LIMITED (IN) 2005-07-14 WO claimed
US-20050042178-A1 Microparticles containing the CGRP-antagonist 1-[N2-[3,5-dibrom-N-[[4-(3,4-dihydro-2(1H)-oxoquinazoline-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine, process for preparing and the use thereof as inhalation powder BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-02-24 US claimed
US-6841665-B2 Method for synthesizing 5β, 6β-epoxides of steroids by a highly β-selective epoxidation of ΔΔ5-unsaturated steroids catalyzed by ketones THE UNIVERSITY OF HONG KONG (CN) 2005-01-11 US claimed
WO-2003074545-A1 METHOD FOR SYNTHESIZING 5ß, 6ß-EPOXIDES OF STEROIDS BY A HIGHLY ß-SELECTIVE EPOXIDATION OF Δ5-UNSATURATED STEROIDS CATALYZED BY KETONES THE UNIVERSITY OF HONG KONG (CN) 2003-09-12 WO claimed
US-20030018188-A1 Method for synthesizing 5beta, 6beta-epoxides of steroids by a highly beta-selective epoxidation of delta5-unsaturated steroids catalyzed by ketones UNIVERSITY OF HONG KONG, THE (HK) 2003-01-23 US claimed
CN-1235972-A Synthesis of 3-EPI vitamin D3 Metabolites and analogs HOFFMANN LA ROCHE (CH) 1999-11-24 CN claimed
EP-0957098-A1 Intermediates for the synthesis of 3-epi vitamin D3 metabolites and analogs F. HOFFMANN-LA ROCHE AG (CH) 1999-11-17 EP claimed
US-5438064-A For suppressing the binding of bradykinins to pain receptors AMERICAN HOME PRODUCTS CORPORATION (US) 1995-08-01 US claimed
EP-0372157-A1 Antidiabetic phosphonates AMERICAN CYANAMID COMPANY (US) 1990-06-13 EP claimed